[128] In contrast, other DAT inhibitors for instance bupropion have not been observed to show this result.[129] These observations have prompted the hypothesis that methylphenidate may perhaps work as a "DAT inverse agonist" or "detrimental allosteric modifier in the DAT" by reversing the path on the dopamine efflux because of the DAT at higher dos